SARS-CoV-2 S RBD IgG, Human

Human IgG ELISA Kit for the Novel Coronavirus Spike Glycoprotein RBD (SARS-CoV-2 S RBD) The Human IgG ELISA Kit for the Novel Coronavirus Spike Glycoprotein RBD (SARS-CoV-2 S RBD) is for the determination of presence or absence of human anti-SARS-CoV-2 spike glycoprotein RBD antibody (IgG) in serum or plasma. SARS-CoV-2 is a coronavirus causing CoVID-19 disease in human. The human immune system will generate different antibodies against viral proteins such as the nuleoprotein and spike proteins. These antibodies include IgM and IgG during different stages of viral infection. This kit is available in 96-, 480- and 960-Assay sizes. ELISA kits come in different assay types like indirect, sandwitch or competitive ELISA to quantitatively or qualitatively measure an analyte's amount, presence or absence. Linear range of detection determines the amount of "target" can be detected accurately, while sensitivity determines the lower range or smallest changes of "target" can be detected. For more information about how ELISA works and types of ELISA, please visit Wikipedia ELISA. Long Names Human anti-SARS-CoV-2 Spike Glycoprotein RBD Antibody (IgG) Sample Type/Volume Serum, plasma - 96 Assays